X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-26 | VRCA | Hayes Christopher G. | GC | S - Sale | $2.61 | -35,713 | 105,773 | -25% | -$93,091 | |||||
| M | 2024-08-26 | VRCA | Goldenberg Gary | Chief Medical Officer | S - Sale | $2.61 | -13,489 | 94,261 | -13% | -$35,161 | |||||
| M | 2024-08-26 | VRCA | Bonaccorso Joe | Chief Commercial Officer | S - Sale | $2.61 | -33,702 | 73,114 | -32% | -$87,849 | |||||
| M | 2024-08-26 | VRCA | Kohler Terry | CFO | S - Sale | $2.61 | -29,719 | 44,697 | -40% | -$77,473 | |||||
| M | 2024-08-26 | VRCA | White Ted | Pres, CEO | S - Sale | $2.61 | -34,000 | 215,967 | -14% | -$88,636 | |||||
| M | 2024-07-22 | VRCA | White Ted | Pres, CEO | S - Sale | $7.06 | -32,623 | 249,967 | -12% | -$230,306 | |||||
| M | 2024-07-22 | VRCA | Bonaccorso Joe | Chief Commercial Officer | S - Sale | $7.06 | -25,576 | 106,816 | -19% | -$180,557 | |||||
| M | 2024-07-22 | VRCA | Goldenberg Gary | Chief Medical Officer | S - Sale | $7.06 | -18,507 | 107,750 | -15% | -$130,653 | |||||
| M | 2024-07-22 | VRCA | Hayes Christopher G. | GC | S - Sale | $7.06 | -21,740 | 141,486 | -13% | -$153,477 | |||||
| M | 2023-12-27 | VRCA | Perceptive Advisors LLC | 10% | P - Purchase | $7.17 | +321,616 | 7,099,182 | +5% | +$2,305,132 | |||||
| M | 2023-12-21 | VRCA | Perceptive Advisors LLC | 10% | P - Purchase | $6.45 | +504,652 | 6,777,566 | +8% | +$3,256,191 | |||||
| M | 2023-12-15 | VRCA | Perceptive Advisors LLC | 10% | P - Purchase | $5.63 | +1,233,931 | 6,272,914 | +24% | +$6,941,716 | |||||
| M | 2023-11-14 | VRCA | Bonaccorso Joe | Chief Commercial Officer | S - Sale | $2.94 | -32,846 | 92,392 | -26% | -$96,689 | |||||
| M | 2023-11-14 | VRCA | Goldenberg Gary | Chief Medical Officer | S - Sale | $2.94 | -8,853 | 86,257 | -9% | -$26,061 | |||||
| M | 2023-11-14 | VRCA | Kohler Terry | CFO | S - Sale | $2.94 | -28,084 | 34,416 | -45% | -$82,671 | |||||
| M | 2023-11-14 | VRCA | White Ted | Pres, CEO | S - Sale | $2.94 | -33,699 | 170,090 | -17% | -$99,200 | |||||
| M | 2023-11-14 | VRCA | Hayes Christopher G. | GC | S - Sale | $2.94 | -33,699 | 123,226 | -21% | -$99,200 | |||||
2023-07-24 | VRCA | Hayes Christopher G. | GC | S - Sale | $4.83 | -33,789 | 81,925 | -29% | -$163,201 | ||||||
2023-07-24 | VRCA | Goldenberg Gary | Chief Medical Officer | S - Sale | $4.83 | -28,699 | 70,110 | -29% | -$138,616 | ||||||
2023-07-24 | VRCA | Bonaccorso Joe | Chief Commercial Officer | S - Sale | $4.83 | -38,262 | 62,738 | -38% | -$184,805 | ||||||
2023-07-24 | VRCA | White Ted | Pres, CEO | S - Sale | $4.83 | -50,677 | 128,789 | -28% | -$244,770 | ||||||
2023-07-24 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $5.02 | +200,000 | 15,589,481 | +1% | +$1,004,000 | ||||||
| A | 2022-07-05 | VRCA | White Ted | Pres, CEO | P - Purchase | $2.10 | +7,500 | 29,466 | +34% | +$15,750 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |